T 6
IVFDaily Links
IVFDaily My account.
IVFdaily is making a few changes during 2019. Open QAPonline Open IVFDaily Open IVFCPD Open IVFBenchmark Open IVFLabOnline
Current FAID=!
Review and Mail Groups
Patient Care
Quality/Clinic Management
List of Web Links for MailGroup: Stimulation
Note: This is the collection of IVFDaily and represents only a fraction of the possible links. If you consider a critically important link is absent, please contact IVFDaily at office@fertaid.com. Please contact IVFDaily if a link no longer appear valid.

Effect of ovarian stimulation on embryo aneuploidy and mosaicism rate
Posted on 1/10/2021 7:31:27 AM [#8844 ]
Risk of breast cancer in women treated with ovarian stimulation drugs for infertility: a systematic review and meta-analysis
Posted on 24/06/2021 9:39:55 AM [#8937 ]
Outcomes comparison of IVF/ICSI among different trigger methods for final oocyte maturation: A systematic review and meta-analysis
Posted on 6/05/2021 8:09:48 PM [#8936 ]
Oocyte competence is independent of the ovulation trigger adopted: a large observational study in a setting that entails vitrified-warmed single euplo
Posted on 3/05/2021 7:58:57 PM [#8893 ]
The Effect of Luteinising Hormone Suppression in In Vitro Fertilisation Antagonist Cycles
Posted on 6/04/2021 10:15:13 AM [#8934 ]
The ovarian sensitivity index is predictive of live birth chances after IVF in infertile patients
Posted on 1/04/2021 12:08:38 AM [#8832 ]
Association between serum oestradiol level on the hCG administration day and neonatal birthweight after IVF-ET among 3659 singleton live births
Posted on 20/03/2021 12:37:59 AM [#8901 ]
ESHRE guideline: ovarian stimulation for IVF/ICSI†
Posted on 17/03/2021 12:22:51 AM [#8897 ]
GnRH agonist and hCG (dual trigger) versus hCG trigger for follicular maturation: a systematic review and meta-analysis of randomized trials
Posted on 6/03/2021 11:58:23 PM [#8933 ]
Time from oocyte retrieval to frozen embryo transfer in the natural cycle does not impact reproductive or neonatal outcomes
Posted on 18/02/2021 12:12:55 AM [#8878 ]
The effect of type of oral contraceptive pill and duration of use on fresh and cumulative live birth rates in IVF/ICSI cycles
Posted on 31/01/2021 8:14:19 AM [#8862 ]
Low dose hCG supplementation in a Gn-RH-agonist trigger protocol is associated with worse pregnancy outcomes: a retrospective cohort study
Posted on 6/01/2021 11:50:01 PM [#8932 ]
Birthweight and other perinatal outcomes of singletons conceived after assisted reproduction compared to natural conceived singletons in couples with
Posted on 24/12/2020 6:58:23 AM [#8822 ]
Effects of vitrification and the superovulated environment on placental function and fetal growth in an IVF mouse model
Posted on 8/11/2020 6:57:28 AM [#8645 ]
Randomized controlled trial comparing embryonic quality in rFSH versus hMG in the IVF protocol with GnRH Antagonist
Posted on 30/10/2020 6:49:22 AM [#8738 ]
The Bologna criteria for the definition of poor ovarian responders: is there a need for revision? [2014]
Posted on 5/10/2020 8:44:39 AM [#8494 ]
Initial ovarian sensitivity index predicts embryo quality and pregnancy potential in the first days of controlled ovarian stimulation
Posted on 19/08/2020 11:20:16 AM [#8657 ]
No effect of ovarian stimulation and oocyte yield on euploidy and live birth rates: an analysis of 12 :298 trophectoderm biopsies
Posted on 5/08/2020 6:23:28 AM [#8492 ]
Increased risk of severe maternal morbidity in women with twin pregnancies resulting from oocyte donation
Posted on 19/07/2020 7:53:04 AM [#8614 ]
Characterization of the Vaginal Microbiome in Women with Infertility and Its Potential Correlation with Hormone Stimulation during In Vitro Fertilizat
Posted on 17/07/2020 7:26:16 AM [#8610 ]
Controlled ovarian stimulation and progesterone supplementation affect vaginal and endometrial microbiota in IVF cycles: a pilot study
Posted on 17/07/2020 7:13:52 AM [#8609 ]
Response to stimulation in IVF may predict longer term health risks
Posted on 12/07/2020 7:14:40 AM [#8600 ]
Response to stimulation in IVF may predict longer term health risks
Posted on 12/07/2020 12:34:44 AM [#8599 ]
Impact of Endometrioma and Bilaterality on IVF / ICSI Cycles in Patients With Endometriosis
Posted on 7/07/2020 11:31:03 PM [#8591 ]
A decision-making algorithm for performing or cancelling embryo transfer in patients at high risk for ovarian hyperstimulation syndrome after triggeri
Posted on 30/06/2020 7:01:37 AM [#8578 ]
GnRH Agonist and hCG (Dual Trigger) Versus hCG Trigger for Final Follicular Maturation: A Double-Blinded, Randomized Controlled Study
Posted on 22/06/2020 4:24:31 PM [#8569 ]
Progesterone supplementation: effects and time optimization [IVF WorldWide presentation].
Posted on 9/06/2020 8:00:10 AM [#8549 ]
Is Ovarian Response Associated With Adverse Perinatal Outcomes in GnRH Antagonist IVF/ICSI Cycles?
Posted on 9/06/2020 12:05:21 AM [#8548 ]
What Is the Best Regimen for Ovarian Stimulation of Poor Responders in ART/IVF?
Posted on 5/06/2020 12:27:48 AM [#8490 ]
Cumulative live birth rates after one ART cycle including all subsequent frozen–thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-
Posted on 3/06/2020 6:29:08 PM [#8536 ]
Cost-effectiveness Analysis of GnRH-agonist Long-Protocol and GnRH-antagonist Protocol for in Vitro Fertilization
Posted on 3/06/2020 6:12:02 PM [#8535 ]
Endometrial compaction before frozen euploid embryo transfer improves ongoing pregnancy rates
Posted on 14/05/2020 11:45:08 PM [#8503 ]
Live birth after frozen–thawed embryo transfer-which endometrial preparation protocol is better?
Posted on 5/05/2020 7:17:16 AM [#8488 ]
Gonadotropin-releasing hormone agonist ovulation trigger—beyond OHSS prevention
Posted on 29/03/2020 10:53:25 PM [#8457 ]
IVF Worldwide Webinar Series: Why and how to supplement androgens in infertile women? Prof. Norbert Gleicher
Posted on 27/03/2020 7:39:15 AM [#8450 ]
Outcomes of in vitro fertilization–embryo transfer in women with diminished ovarian reserve after growth hormone pretreatment
Posted on 18/03/2020 12:00:25 AM [#8441 ]
Effect of oocyte donor stimulation on recipient outcomes: data from a US national donor oocyte bank
Posted on 8/03/2020 7:44:43 AM [#8426 ]
Ovarian Stimulation Is Safe and Effective for Patients with Gynecologic Cancer
Posted on 14/01/2020 1:05:59 AM [#8366 ]
Individualized ovarian stimulation in IVF/ICSI treatment: it is time to stop using high FSH doses in predicted low responders
Posted on 17/12/2019 12:14:44 AM [#8338 ]
The POSEIDON Criteria and Its Measure of Success Through the Eyes of Clinicians and Embryologists
Posted on 13/12/2019 7:30:15 AM [#8335 ]
Comparative study between agonist and antagonist protocols in PCOS patients undergoing ICSI: a cross-sectional study
Posted on 12/12/2019 12:19:14 AM [#8331 ]
Dehydroepiandrosterone Supplementation Improves the Outcomes of in vitro Fertilization Cycles in Older Patients With Diminished Ovarian Reserve
Posted on 10/12/2019 12:22:25 AM [#8330 ]
Future Perspectives of POSEIDON Stratification for Clinical Practice and Research
Posted on 10/12/2019 12:19:31 AM [#8329 ]
The novel POSEIDON stratification of ‘Low prognosis patients in Assisted Reproductive Technology’ and its proposed marker of successful outcome
Posted on 10/12/2019 12:16:15 AM [#8328 ]
Live birth outcomes of vitrified embryos generated under growth hormone stimulation are improved for women categorized as poor-prognosis
Posted on 23/11/2019 6:16:25 AM [#8309 ]
Differential impacts of gonadotrophins, IVF and embryo culture on mouse blastocyst development [Mouse]
Posted on 6/11/2019 11:14:19 AM [#8292 ]
The Concept of Growth Hormone Deficiency Affecting Clinical Prognosis in IVF
Posted on 24/10/2019 7:02:50 AM [#8284 ]
Repeated GnRH agonist doses for luteal support: a proof of concept
Posted on 24/10/2019 6:59:36 AM [#8283 ]
Low LH Level on the Day of GnRH Agonist Trigger Is Associated With Reduced Ongoing Pregnancy and Live Birth Rates and Increased Early Miscarriage Rate
Posted on 19/10/2019 12:02:47 AM [#8275 ]
Growth Hormone and Endometrial Receptivity - a mini review.
Posted on 18/10/2019 6:10:00 AM [#8271 ]
Embryonic aneuploidy rates are equivalent in natural cycles and gonadotropin-stimulated cycles
Posted on 8/10/2019 [#8263 ]
The effect of anesthetic agents for oocyte pick-up on in vitro fertilization outcome: A retrospective study in a tertiary center
Posted on 26/09/2019 11:29:08 PM [#8255 ]
The effect of repeated controlled ovarian stimulation cycles on the gamete and embryo development
Posted on 20/08/2019 6:30:53 AM [#8227 ]
Ovarian stimulation for preimplantation genetic testing
Posted on 3/08/2019 11:33:33 PM [#8083 ]
Growth Hormone and Reproduction: Lessons Learned From Animal Models and Clinical Trials
Posted on 17/07/2019 9:27:40 AM [#8207 ]
Supraphysiological serum oestradiol negatively affects birthweight in cryopreserved embryo transfers: a retrospective cohort study
Posted on 4/07/2019 9:04:22 AM [#8195 ]
Controlled ovarian hyperstimulation (COH) parameters associated with euploidy rates in donor oocytes
Posted on 3/07/2019 12:19:07 AM [#8194 ]
In vitro fertilisation was associated with refractive errors when children reached the age of 11
Posted on 19/06/2019 6:34:18 AM [#8174 ]
Ocular Malformations or Poor Visual Acuity in Children Born After In Vitro Fertilization in Sweden [2010 report]
Posted on 19/06/2019 6:30:29 AM [#8173 ]
Required amount of rFSH, HP-hMG and HP-FSH to reach a live birth: a systematic review and meta-analysis
Posted on 19/06/2019 6:11:28 AM [#8171 ]
Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility [update]
Posted on 19/06/2019 6:00:22 AM [#8170 ]
Understanding Follicular Output Rate (FORT) and its Implications for POSEIDON Criteria
Posted on 3/05/2019 12:10:09 PM [#8142 ]
The impact of adding hp-hMG in r-FSH started GnRH antagonist cycles on ART outcome
Posted on 13/04/2019 12:00:11 AM [#8129 ]
Corifollitropin alfa for ovarian stimulation in in vitro fertilization: a systematic review and meta-analysis of randomized controlled trials
Posted on 3/04/2019 7:32:28 AM [#8123 ]
Evaluation of the Second Follicular Wave Phenomenon in Natural Cycle Assisted Reproduction: A Key Option for Poor Responders through Luteal Phase Oocy
Posted on 17/03/2019 11:49:03 PM [#8092 ]
Dual stimulation using corifollitropin alfa in 54 Bologna criteria poor ovarian responders – a case series
Posted on 25/02/2019 10:45:23 AM [#8069 ]
Endogenous progesterone levels could predict reproductive outcome in frozen embryo replacement cycles supplemented with synthetic progestogens: A retr
Posted on 21/01/2019 8:42:18 AM [#8040 ]
Dual trigger with gonadotropin releasing hormone agonist and human chorionic gonadotropin significantly improves live birth rate for women with dimini
Posted on 7/01/2019 11:36:49 PM [#8019 ]
Only women’s age and the duration of infertility are the prognostic factors for the success rate of natural cycle IVF
Posted on 7/01/2019 11:32:22 PM [#8018 ]
Ovarian stimulation and endometriosis progression or recurrence: a systematic review
Posted on 7/01/2019 11:28:16 PM [#8017 ]
Testosterone therapy for women with poor ovarian response undergoing IVF: a meta-analysis of randomized controlled trials
Posted on 7/01/2019 11:22:45 PM [#8016 ]
Soluble LH-hCG receptor and oestradiol as predictors of pregnancy and live birth in IVF
Posted on 3/01/2019 7:29:01 AM [#8015 ]
Follitropin delta in repeated ovarian stimulation for IVF: a controlled, assessor-blind Phase 3 safety trial
Posted on 1/01/2019 5:09:46 PM [#8011 ]
Evaluating the benefit of measuring serum progesterone prior to the administration of hCG: effect of the duration of late-follicular elevated progeste
Posted on 1/01/2019 5:00:01 PM [#8009 ]
High responders are not exempt from detrimental effects of prematurely rising progesterone levels in fresh embryo transfer cycles
Posted on 27/12/2018 9:59:58 AM [#7997 ]
Platelet-Rich Plasma (PRP) for Ovarian Rejuvenation
Posted on 19/12/2018 12:04:26 PM [#7984 ]
Urinary versus recombinant gonadotropins for ovarian stimulation in women undergoing treatment with assisted reproductive technology
Posted on 3/09/2018 7:07:52 AM [#7868 ]
A Case Series on Platelet-Rich Plasma Revolutionary Management of Poor Responder Patients
Posted on 25/08/2018 1:07:27 AM [#7854 ]
The effect of female body mass index on in vitro fertilization cycle outcomes: a multi-center analysis
Posted on 9/05/2018 7:09:10 AM [#7874 ]
Is gonadotropin stimulation bad for oocytes?
Posted on 4/05/2018 12:01:19 AM [#7809 ]
Effect of Growth Hormone on Uterine Receptivity in Women With Repeated Implantation Failure in an Oocyte Donation Program: A Randomized Controlled Tri
Posted on 3/02/2018 3:43:00 PM [#7761 ]
Preconception use of pain-relievers and time-to-pregnancy: a prospective cohort study
Posted on 3/02/2018 3:30:01 PM [#7757 ]
Low dosing of gonadotropins in in vitro fertilization cycles for women with poor ovarian reserve: systematic review and meta-analysis [Meta Analysis]
Posted on 17/01/2018 12:07:12 AM [#7722 ]
ANDRO-IVF: a novel protocol for poor responders to IVF controlled ovarian stimulation. [PDF Download]
Posted on 10/01/2018 9:15:09 AM [#7717 ]
Does freeze-all policy affect IVF outcomes in poor responders?
Posted on 6/01/2018 3:24:33 PM [#7711 ]
Ovarian response to controlled ovarian stimulation in women with different polycystic ovary syndrome phenotypes
Posted on 29/12/2017 12:32:48 AM [#7707 ]
Impact of insulin resistance and obesity on intracytoplasmic sperm injection outcomes in young women with polycystı:c ovary syndrome
Posted on 29/12/2017 12:18:47 AM [#7705 ]
A second dose of kisspeptin-54 improves oocyte maturation in women at high risk of ovarian hyperstimulation syndrome: a Phase 2 randomized controlled
Posted on 7/11/2017 3:51:16 PM [#7671 ]
Single-centre retrospective analysis of growth hormone supplementation in IVF patients classified as poor-prognosis
Posted on 14/10/2017 11:07:45 AM [#7655 ]
Outcomes from a university-based low-cost in vitro fertilization program providing access to care for a low-resource socioculturally diverse urban com
Posted on 8/09/2017 10:53:28 AM [#7628 ]
Controlled ovulation of the dominant follicle using progestin in minimal stimulation in poor responders
Posted on 6/09/2017 5:25:17 PM [#7625 ]
The superovulated environment, independent of embryo vitrification, results in low birthweight in a mouse model
Posted on 4/09/2017 10:46:36 AM [#7617 ]
Inositol and In Vitro Fertilization with Embryo Transfer
Posted on 22/05/2017 5:21:41 PM [#7575 ]
High FSH dosing is associated with reduced live birth rate in fresh but not subsequent frozen embryo transfers
Posted on 21/05/2017 7:03:37 AM [#7569 ]
Top quality blastocyst formation rates in relation to progesterone levels on the day of oocyte maturation in GnRH antagonist IVF/ICSI cycles
Posted on 20/05/2017 7:28:35 AM [#7566 ]
Effectiveness of mild ovarian stimulation versus GnRH agonist protocol in women undergoing assisted reproductive technology: a meta-analysis
Posted on 18/05/2017 7:13:27 AM [#7554 ]
Pharmacokinetic, pharmacodynamic, and clinical aspects of ovulation induction agents: A review of the literature
Posted on 18/05/2017 7:09:59 AM [#7553 ]
Management of ovarian stimulation for IVF: narrative review of evidence provided for World Health Organization guidance
Posted on 16/05/2017 7:09:50 AM [#7545 ]
Progesterone/estradiol ratio <0.25 on the day of human chorionic gonadotropin administration is associated with adverse pregnancy outcomes in prolonge
Posted on 8/03/2017 7:50:19 AM [#7508 ]
GnRH antagonist and letrozole co-treatment in diminished ovarian reserve patients: a proof-of-concept study.[Pubmed link].
Posted on 18/02/2017 11:16:35 AM [#7482 ]
Ovarian stimulation protocols for IVF: is more better than less?
Posted on 18/02/2017 11:11:54 AM [#7481 ]
PIVET rFSH dosing algorithms for individualized controlled ovarian stimulation enables optimized pregnancy productivity rates and avoidance of ovarian
Posted on 29/08/2016 12:02:12 AM [#7384 ]
Infertility: Australian scientists work to eliminate hormone injections with IVM treatment
Posted on 25/08/2016 9:30:42 AM [#7373 ]
The impact of progesterone supplementation on pregnancy rates after intrauterine insemination in patients developing a single follicle
Posted on 25/08/2016 8:53:52 AM [#7372 ]
Does poor ovarian response to gonadotrophins predict early menopause? A retrospective cohort study with minimum of 10-year follow-up
Posted on 25/08/2016 7:24:06 AM [#7371 ]
Treatment of infertility does not increase the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation
Posted on 24/08/2016 8:26:16 AM [#7370 ]
Growth hormone co-treatment within a GnRH agonist long protocol improves implantation and pregnancy rates in patients undergoing IVF-ET
Posted on 9/08/2016 6:47:15 AM [#6341 ]
Still no strong evidence that adjunctive treatment with human growth hormone in IVF improves results
Posted on 28/07/2016 5:50:11 PM [#6307 ]
Superovulation Using the Combined Administration of Inhibin Antiserum and Equine Chorionic Gonadotropin Increases the Number of Ovulated Oocytes in C5
Posted on 23/06/2015 7:31:41 AM [#6224 ]
Successful ovulation of 100 eggs from one female mouse
Posted on 23/06/2015 7:30:19 AM [#6223 ]
Comparative prospective study of 2 ovarian stimulation protocols in poor responders: effect on implantation rate and ongoing pregnancy
Posted on 5/06/2015 7:31:39 AM [#6212 ]
Effects of female increased body mass index on in vitro fertilization cycles outcome
Posted on 17/03/2015 11:40:24 PM [#6156 ]
Twenty years’ experience with the Swiss data registry for assisted reproductive medicine: outcomes, key trends and recommendations for improved practi
Posted on 11/02/2015 11:56:24 PM [#6130 ]
Randomized, controlled, open-label, non-inferiority study of the CONSORT algorithm for individualized dosing of follitropin alfa
Posted on 6/02/2015 9:01:44 AM [#6120 ]
Timing luteal support in assisted reproductive technology: a systematic review
Posted on 6/02/2015 8:39:20 AM [#6115 ]
Efficacy and safety of late-start Corifollitropin-alfa administration for controlled ovarian hyperstimulation in IVF: a cohort, case–control study
Posted on 19/01/2015 9:33:14 AM [#6089 ]
Estimating the net effect of progesterone elevation on the day of hCG on live birth rates after IVF: a cohort analysis of 3296 IVF cycles
Posted on 19/01/2015 9:21:26 AM [#6087 ]
The dynamic changes of anti-Mullerian hormone and inhibin B during controlled ovarian hyperstimulation in decreased ovarian reserve women and the effe
Posted on 19/01/2015 9:10:35 AM [#6085 ]
Comparison of hCG triggering versus hCG in combination with a GnRH agonist: a prospective randomized controlled trial
Posted on 19/01/2015 8:51:05 AM [#6082 ]
Couple who spent £20,000 on IVF finally have a baby thanks to egg yolk and soya treatment.
Posted on 1/10/2014 7:58:42 AM [#6012 ]
Low-Cost IVF In Australia Shows Promise For Only $800
Posted on 1/10/2014 7:54:39 AM [#6011 ]
The impact of the time interval on in-vitro fertilisation success after failure of the first attempt.
Posted on 30/09/2014 10:34:26 PM [#6010 ]
Pituitary suppression with a GnRHa short protocol in an alternate day schedule associated with rhCG microdoses
Posted on 20/08/2014 5:34:20 PM [#5981 ]
Perinatal outcomes in 6,338 singletons born after intrauterine insemination in Denmark, 2007 to 2012: the influence of ovarian stimulation
Posted on 28/07/2014 2:35:52 PM [#5955 ]
Evaluation of kisspeptin-54 for egg maturation
Posted on 20/07/2014 5:29:24 AM [#5939 ]
Kisspeptin-54 triggers egg maturation in women undergoing in vitro fertilization
Posted on 20/07/2014 4:33:49 AM [#5938 ]
'Safer IVF' with kisspeptin hormone shows promise
Posted on 20/07/2014 4:30:43 AM [#5937 ]
Effect of pretreatment with transdermal testosterone on poor ovarian responders undergoing IVF/ICSI: A meta-analysis
Posted on 12/07/2014 8:36:58 AM [#5917 ]
Letrozole versus Clomiphene for Infertility in the Polycystic Ovary Syndrome
Posted on 11/07/2014 4:41:10 PM [#5913 ]
Letrozole may help women with polycystic ovary syndrome become pregnant
Posted on 11/07/2014 4:39:45 PM [#5912 ]
Sequential (hFSH + recFSH) vs homogenous (hFSH or recFSH alone) stimulation: clinical and biochemical (cumulus cell gene expression) aspects
Posted on 8/07/2014 4:29:21 PM [#5896 ]
No link between fertility drugs and breast, ovarian, uterine cancers, study finds
Posted on 2/07/2014 6:05:23 AM [#5874 ]
No link between fertility drugs and breast, ovarian and uterine cancers
Posted on 1/07/2014 8:05:26 AM [#5865 ]
Efficacy doubts over pre-IVF hysteroscopy
Posted on 1/07/2014 8:00:54 AM [#5863 ]
GnRH antagonist versus long GnRH agonist protocol in poor IVF responders: a randomized clinical trial
Posted on 27/06/2014 5:58:34 PM [#5852 ]
Live birth rates after IVF are reduced by both low and high progesterone levels on the day of human chorionic gonadotrophin administration
Posted on 27/06/2014 7:03:02 AM [#5850 ]
Association between intrafollicular concentration of benzene and outcome of controlled ovarian stimulation in IVF/ICSI cycles: a pilot study
Posted on 25/06/2014 9:15:53 AM [#5839 ]
A randomized clinical trial to determine optimal infertility treatment in older couples: the Forty and Over Treatment Trial (FORT-T)
Posted on 8/06/2014 9:24:06 AM [#5802 ]
Elevated fetal steroidogenic activity in autism
Posted on 4/06/2014 8:53:01 AM [#5790 ]
Children with autism have elevated levels of steroid hormones in the womb
Posted on 4/06/2014 8:51:19 AM [#5789 ]
Clinical rationale for cryopreservation of entire embryo cohorts in lieu of fresh transfer
Posted on 31/05/2014 7:57:35 AM [#5779 ]
Coasting, embryo development and outcomes of blastocyst transfer: a case–control study
Posted on 27/05/2014 6:04:58 AM [#5749 ]
Is there a critical endometrioma size associated with reduced ovarian responsiveness in assisted reproduction techniques?
Posted on 27/05/2014 6:01:07 AM [#5748 ]
Impact of high serum progesterone during the late follicular phase on IVF outcome
Posted on 27/05/2014 5:45:33 AM [#5745 ]
The rate of high ovarian response in women identified at risk by a high serum AMH level is influenced by the type of gonadotropin. [OPEN ACCESS]
Posted on 14/05/2014 5:39:54 AM [#5721 ]
Adding serum estradiol measurements to ultrasound monitoring does not change the yield of mature oocytes in IVF/ICSI.
Posted on 13/05/2014 6:28:54 PM [#5720 ]
Altered glucose metabolism in mouse and humans conceived by in-vitro fertilization (IVF)
Posted on 1/05/2014 9:22:12 PM [#5686 ]
AMH: its role in selecting the Stimulation protocol, Gonadotropin dosage and Egg quality [Powerpoint Presentation]
Posted on 1/05/2014 7:30:50 AM [#5675 ]
Worldwide survey of IVF practices: trigger, retrieval and embryo transfer techniques
Posted on 21/04/2014 9:07:01 AM [#5632 ]
What a difference two days make: “personalized” embryo transfer (pET) paradigm: A case report and pilot study
Posted on 19/04/2014 10:19:48 AM [#5627 ]
Cumulative Delivery Rate after Providing Full Reimbursement In Vitro Fertilization Programme: A 6-Years Survey
Posted on 19/04/2014 8:30:37 AM [#5626 ]
Multiple births don't have to be an inevitable result of fertility treatments
Posted on 17/04/2014 5:55:05 AM [#5623 ]
Embryological, clinical and ultrastructural study of human oocytes presenting indented zona pellucida
Posted on 16/04/2014 8:13:50 AM [#5618 ]
Efficacy of dehydroepiandrosterone to improve ovarian response in women with diminished ovarian reserve: a meta-analysis [2013 review]
Posted on 14/04/2014 8:55:09 AM [#5603 ]
DHEA pre-treated patients, poor responders to a first IVF (ICSI) cycle: clinical results.
Posted on 14/04/2014 8:51:08 AM [#5602 ]
“Mild” vs. “long” protocol for controlled ovarian hyperstimulation in patients with expected poor ovarian responsiveness undergoing in vitro fertiliza
Posted on 11/04/2014 10:42:00 AM [#5596 ]
Type of Conception and Outcomes in Women with Singleton Pregnancy
Posted on 8/04/2014 1:53:50 PM [#5590 ]
A novel “delayed start” protocol with gonadotropin-releasing hormone antagonist improves outcomes in poor responders
Posted on 5/04/2014 12:40:50 PM [#5584 ]
Is the modified natural in vitro fertilization cycle justified in patients with “genuine” poor response to controlled ovarian hyperstimulation?
Posted on 5/04/2014 12:36:05 PM [#5583 ]
HCG (1500IU) administration on day 3 after oocytes retrieval, following GnRH-agonist trigger for final follicular maturation, results in high sufficie
Posted on 4/04/2014 9:58:51 PM [#5578 ]
Miscarriage risk linked to low IVF success
Posted on 25/03/2014 9:30:40 AM [#5564 ]
FDA Approves Combo IVF Drugs for Infertility
Posted on 21/03/2014 10:22:06 AM [#5553 ]
Spermatid count as a predictor of response to FSH therapy
Posted on 21/03/2014 10:09:39 AM [#5549 ]
Role of dehydroepiandrosterone in improving oocyte and embryo quality in IVF cycles
Posted on 21/03/2014 9:33:19 AM [#5541 ]
Foreigners seek IVF, plastic surgery at Czech clinics
Posted on 12/03/2014 9:59:26 AM [#5535 ]
Androgens regulate ovarian follicular development by increasing follicle stimulating hormone receptor and microRNA-125b expression
Posted on 5/03/2014 11:55:54 AM [#5525 ]
Female fertility: What's testosterone got to do with it? Research shows male hormones may enhance IVF therapy
Posted on 5/03/2014 11:54:26 AM [#5524 ]
Hypo-glycosylated human follicle-stimulating hormone (hFSH21/18) is much more active in vitro than fully-glycosylated hFSH (hFSH24)
Posted on 6/02/2014 9:05:16 AM [#5448 ]
Luteinizing hormone and human chorionic gonadotropin: Origins of difference [Open Access]
Posted on 6/02/2014 8:55:25 AM [#5447 ]
First live births with a novel simplified IVF procedure
Posted on 5/02/2014 2:47:02 PM [#5444 ]
Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles
Posted on 31/01/2014 5:00:33 AM [#4438 ]
First baby is born here to couple using new method of IVF
Posted on 18/01/2014 8:32:45 PM [#4409 ]
Could empirical low-dose-aspirin administration during IVF cycle affect both the oocytes and embryos quality via COX 1–2 activity inhibition?
Posted on 18/01/2014 8:13:41 PM [#4404 ]
Enzyme-linked immunosorbent assay measurements of antimüllerian hormone (AMH) in human blood are a composite of the uncleaved and bioactive cleaved fo
Posted on 16/01/2014 2:47:05 PM [#4397 ]
Higher Risk of Birth Problems After Assisted Conception
Posted on 13/01/2014 2:54:13 PM [#4393 ]
Continuous high-dose estrogen controls serum FSH and LH levels: new treatment strategy for extremely low ovarian reserve patients, two case reports.
Posted on 11/01/2014 12:11:33 PM [#4385 ]
Is ovarian hyperstimulation associated with higher blood pressure in 4-year-old IVF offspring? Part I: multivariable regression analysis
Posted on 11/01/2014 10:47:55 AM [#4384 ]
Cabergoline for the prevention of ovarian hyperstimulation syndrome: systematic review and meta-analysis of randomized controlled trials
Posted on 21/12/2013 10:27:43 AM [#4350 ]
Ovarian sensitivity index is a better measure of ovarian responsiveness to gonadotrophin stimulation than the number of oocytes during in-vitro fertil
Posted on 15/12/2013 10:39:08 AM [#4333 ]
IVF with planned single-embryo transfer versus IUI with ovarian stimulation in couples with unexplained subfertility: an economic analysis
Posted on 8/12/2013 10:40:55 PM [#4320 ]
Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice
Posted on 5/12/2013 4:06:11 PM [#4312 ]
Low-dose metformin improves pregnancy rate in in vitro fertilization repeaters without polycystic ovary syndrome: Prediction of effectiveness by multi
Posted on 5/12/2013 12:26:59 PM [#4310 ]
Can we prevent premature luteinization in IVF cycles?
Posted on 5/12/2013 12:21:07 PM [#4309 ]
Association Between AMH, Oocyte Number and Availability of Embryos for Cryopreservation in IVF
Posted on 5/12/2013 11:41:25 AM [#4308 ]
The impact of legally restricted embryo transfer and reimbursement policy on cumulative delivery rate after treatment with assisted reproduction techn
Posted on 28/11/2013 4:12:08 PM [#4291 ]
Delivery Rates Unaffected by Transferring Fewer Embryos, Reimbursing Six Cycles of Fertility Treatment
Posted on 28/11/2013 4:09:55 PM [#4290 ]
Multiple births to older mothers soars
Posted on 22/11/2013 7:49:33 PM [#4288 ]
Differences in cumulus cells gene expression between modified natural and stimulated in vitro fertilization cycles
Posted on 20/11/2013 8:09:21 AM [#4273 ]
Anti-Mullerian hormone: reality check
Posted on 17/11/2013 8:30:34 AM [#4257 ]
Ovarian response markers lead to appropriate and effective use of corifollitropin alpha in assisted reproduction
Posted on 31/10/2013 9:34:44 AM [#4226 ]
'Mini-IVF,' using fewer drugs, sees greater success in women over 35
Posted on 21/10/2013 7:04:59 AM [#4193 ]
Comparison of early versus late initiation of GnRH antagonist co-treatment for controlled ovarian stimulation in IVF: a randomized controlled trial
Posted on 18/10/2013 9:49:18 PM [#4174 ]
IVF endocrinology: the Edwards era
Posted on 18/10/2013 9:35:09 PM [#4170 ]
Efficacy and safety of IVF/ICSI in patients with severe endometriosis after long-term pituitary down-regulation
Posted on 13/10/2013 3:51:35 PM [#4160 ]
Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice
Posted on 3/10/2013 6:47:53 PM [#4125 ]
Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment
Posted on 2/10/2013 8:53:31 AM [#4116 ]
Accumulation of oocytes from a few modified natural cycles to improve IVF results: a pilot study
Posted on 2/10/2013 8:26:48 AM [#4112 ]
Involvement of androgens in ovarian health and disease
Posted on 2/10/2013 8:21:10 AM [#4111 ]
‘IVF lite’ delivers its first baby
Posted on 29/09/2013 8:10:27 AM [#4098 ]
Influence of FSHR Diplotypes on Ovarian Response to Standard Gonadotropin Stimulation for IVF/ICSI
Posted on 21/09/2013 6:48:45 PM [#4072 ]
Long-term pituitary downregulation before frozen embryo transfer could improve pregnancy outcomes in women with adenomyosis
Posted on 8/09/2013 9:40:25 AM [#4021 ]
The Measurement of Anti-Müllerian Hormone (AMH)
Posted on 8/09/2013 9:37:00 AM [#4020 ]
Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate fo
Posted on 8/09/2013 9:13:39 AM [#4013 ]
Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate fo
Posted on 1/09/2013 11:29:03 PM [#3986 ]
What is the optimal means of preparing the endometrium in frozen–thawed embryo transfer cycles? A systematic review and meta-analysis
Posted on 1/09/2013 11:26:02 PM [#3985 ]
Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG
Posted on 1/09/2013 11:24:08 PM [#3984 ]
Low-dose hCG supplementation after GnRH agonist triggering: don't be too quick on the trigger
Posted on 1/09/2013 11:18:07 PM [#3982 ]
Controlled ovarian hyperstimulation regimens: a review of the available evidence for clinical practice. On behalf of the British Fertility Society P&P
Posted on 19/08/2013 6:14:54 PM [#3955 ]
Using the ovarian sensitivity index to define poor, normal, and high response after controlled ovarian hyperstimulation in the long gonadotropin-relea
Posted on 16/08/2013 3:54:22 PM [#3951 ]
Effects of caloric intake timing on insulin resistance and hyperandrogenism in lean women with polycystic ovary syndrome
Posted on 14/08/2013 10:54:05 PM [#3942 ]
Meal Timing Can Significantly Improve Fertility in Women With Polycystic Ovaries
Posted on 14/08/2013 10:52:42 PM [#3941 ]
DHEA supplementation positively affects spontaneous pregnancies in women with diminished ovarian function.
Posted on 31/07/2013 10:32:17 PM [#3898 ]
Modified Fixed Two Step Short Protocol versus Classic Short Protocol in ICSI
Posted on 26/07/2013 6:49:18 AM [#3877 ]
Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH
Posted on 25/07/2013 5:36:19 PM [#3869 ]
Establishing a combined stimulation protocol hFSH followed by rFSH might represent a breakthrough in the IVF practice
Posted on 23/07/2013 9:45:10 AM [#3866 ]
Simultaneous administration of human acidic and recombinant less acidic follicle-stimulating hormone for ovarian stimulation improves oocyte and embry
Posted on 23/07/2013 9:42:18 AM [#3865 ]
High live birth rate in the subsequent IVF cycle after first-cycle poor response among women with mean age 35 and normal FSH
Posted on 20/07/2013 7:05:09 AM [#3847 ]
FSH receptor genotype does not predict metaphase-II oocyte output or fertilization rates in ICSI patients
Posted on 2/07/2013 4:49:14 PM [#3818 ]
Follicle recruitment determines IVF productivity rate via the number of embryos frozen and subsequent transfers
Posted on 29/06/2013 3:41:55 PM [#3814 ]
First baby born using new lower risk IVF treatment
Posted on 18/06/2013 3:11:34 PM [#2792 ]
Hormone breakthrough offers hope of safer fertility treatment
Posted on 18/06/2013 3:08:52 PM [#2791 ]
IVF: First baby born using 'safer' method
Posted on 18/06/2013 3:06:15 PM [#2790 ]
Oocyte-derived R-spondin2 promotes ovarian follicle development
Posted on 1/06/2013 4:07:38 PM [#2780 ]
Newly Discovered Hormone Makes Ovaries Grow
Posted on 1/06/2013 4:04:31 PM [#2779 ]
Metabolite Profiling in the Pursuit of Biomarkers for IVF Outcome: The Case for Metabolomics Studies
Posted on 25/01/2013 8:22:49 AM [#2658 ]
Immature Oocytes in “Apparent Empty Follicle Syndrome”: A Case Report
Posted on 25/01/2013 8:19:15 AM [#2657 ]
Luteal phase support for assisted reproduction cycles
Posted on 23/11/2012 8:34:37 AM [#2582 ]
In vitro fertilisation for unexplained subfertility
Posted on 23/11/2012 8:31:29 AM [#2581 ]
Ovarian hyperstimulation syndrome and prophylactic human embryo cryopreservation: analysis of reproductive outcome following thawed ET
Posted on 23/11/2012 8:18:30 AM [#2578 ]
Perifollicular blood flow and pregnancy in superovulated intrauterine insemination (IUI) cycles: An observational comparison of recombinant follicle-s
Posted on 4/10/2012 8:28:39 AM [#2468 ]
Follicular fluid VEGF levels directly correlate with perifollicular blood flow in normoresponder patients undergoing IVF.
Posted on 4/10/2012 8:02:45 AM [#2469 ]
Effects of transdermal testosterone in poor responders undergoing IVF: systematic review and meta-analysis
Posted on 22/09/2012 8:34:49 AM [#2447 ]
Altered gene expression profile in cumulus cells of mature MII oocytes from patients with polycystic ovary syndrome
Posted on 7/09/2012 9:18:30 AM [#2406 ]
An updated survey: the use of progesterone for luteal phase support.
Posted on 20/08/2012 7:18:20 AM [#2369 ]
Psychological stress and reproductive aging among pre-menopausal women
Posted on 11/08/2012 11:07:08 AM [#2349 ]
Serum FSH Levels in Coasting Programmes on the hCG Day and Their Clinical Outcomes in IVF ± ICSI Cycles
Posted on 18/07/2012 5:13:05 PM [#2303 ]
Fertility Drugs and Young-Onset Breast Cancer: Results From the Two Sister Study
Posted on 7/07/2012 12:13:51 PM [#2254 ]
Breast Cancer Risk After Use of Fertility Drugs: Stimulating New Controversy
Posted on 7/07/2012 12:07:56 PM [#2253 ]
Unsuccessful Fertility Drug Users Have Reduced Breast Cancer Risk, Study Suggests
Posted on 7/07/2012 12:06:35 PM [#2252 ]
A high intake of certain dietary fats associated with lower live birth rates, decreased oocyte number and poorer embryo quality in IVF
Posted on 4/07/2012 11:10:42 AM [#2237 ]
Full-Term Children Conceived With Fertility Drugs Are Shorter Than Their Peers
Posted on 26/06/2012 10:53:03 PM [#2203 ]
Long-acting FSH versus daily FSH for women undergoing assisted reproduction
Posted on 15/06/2012 11:45:02 AM [#2176 ]
New Weekly Fertility Injections Work as Well as Daily, Study Suggests
Posted on 15/06/2012 11:43:38 AM [#2175 ]
Effect of hCG priming on embryonic development of immature oocytes collected from unstimulated women with polycystic ovarian syndrome
Posted on 28/05/2012 11:41:38 PM [#2125 ]
GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology
Posted on 28/05/2012 11:39:05 PM [#2124 ]
Accumulation of oocytes: a new strategy for managing low-responder patients
Posted on 23/05/2012 9:56:21 AM [#2086 ]
Individualised controlled ovarian stimulation (iCOS): maximising success rates for assisted reproductive technology patients
Posted on 20/05/2012 9:50:50 AM [#2076 ]
Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose hCG OHSS
Posted on 8/04/2012 8:42:43 AM [#1984 ]
Luteal phase support for assisted reproduction cycles
Posted on 3/04/2012 8:09:12 AM [#1969 ]
Elevated progesterone during ovarian stimulation for IVF
Posted on 22/03/2012 8:49:00 AM [#1945 ]
Discovery of a Molecule That Initiates Maturation of Mammalian Eggs Can Lead to More IVF Pregnancies
Posted on 7/03/2012 9:28:09 AM [#1893 ]
Targeted gonadotrophin stimulation using the PIVET algorithm markedly reduces the risk of OHSS
Posted on 6/03/2012 7:56:01 AM [#1884 ]
Meta-analysis of GnRH antagonist protocols: do they reduce the risk of OHSS in PCOS?
Posted on 20/01/2012 8:54:33 AM [#1847 ]
Patient preferences for characteristics differentiating ovarian stimulation treatments
Posted on 13/01/2012 9:26:01 AM [#1837 ]
Anti-Müllerian hormone: clairvoyance or crystal clear?
Posted on 13/01/2012 9:17:17 AM [#1835 ]
Similarly increased congenital anomaly rates after intrauterine insemination and IVF technologies: a
Posted on 13/01/2012 9:13:44 AM [#1834 ]
Lack of association between endogenous LH and pregnancy in GnRH antagonist protocols
Posted on 6/12/2011 7:09:18 AM [#1815 ]
Oestradiol valerate pretreatment in GnRH-antagonist cycles: a randomized controlled trial
Posted on 6/12/2011 7:07:38 AM [#1814 ]
Anti-Müllerian hormone-tailored stimulation protocols improve outcomes whilst reducing adverse effec
Posted on 24/11/2011 1:43:21 PM [#1804 ]
Premature LH surges do not affect pregnancy rates with unstimulated-cycle frozen–thawed embryo trans
Posted on 19/11/2011 8:28:16 AM [#1797 ]
Perspectives of mild cycle IVF: a qualitative study
Posted on 9/11/2011 7:31:41 AM [#1771 ]
Interview with Prof. Alviggi
Posted on 3/11/2011 9:59:28 AM [#1766 ]
Individualized COS to optimize the quantity and quality of oocytes and embryos generated in ART cycl
Posted on 3/11/2011 9:57:45 AM [#1765 ]
Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization
Posted on 1/11/2011 10:19:06 AM [#1757 ]
Clinical use of a model to predict the viability of early intrauterine pregnancies when no embryo is
Posted on 25/10/2011 9:07:42 PM [#1740 ]
Publish or perish: a maxim relevant to authors, readers and editors alike
Posted on 7/09/2011 10:23:34 AM [#1652 ]
Anti-Mullerian Hormone and the Embryologist
Posted on 20/08/2011 9:28:54 AM [#1624 ]
Assisted procreation and its impact on couple sexuality Valentino Valeria
Posted on 17/08/2011 11:18:03 AM [#1614 ]
A standardized measurement technique may improve the reliability of measurements of endometrial thic
Posted on 14/08/2011 3:06:38 PM [#1596 ]
Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a
Posted on 14/08/2011 8:42:08 AM [#1585 ]
Corifollitropin alfa doses based on body weight: clinical overview of drug exposure and ovarian resp
Posted on 9/08/2011 4:27:02 PM [#1569 ]
A single nucleotide polymorphism in BMP15 is associated with high response to controlled ovarian hyp
Posted on 29/07/2011 2:41:03 PM [#1536 ]
IVF Treatment and Multiple Births: Free-Market Patient Rights Versus Government Regulation
Posted on 29/07/2011 2:34:25 PM [#1534 ]
Lottery offers IVF treatment prize
Posted on 17/07/2011 11:17:54 PM [#1529 ]
DHEA as a miracle drug in the treatment of poor responders: hype or hope?
Posted on 16/07/2011 8:34:32 AM [#1521 ]
Betting for a baby: To Hatch launches an IVF lottery
Posted on 12/07/2011 5:14:05 PM [#1516 ]
Simple Test Gives Accurate Prediction of Ovulation to Help Women Become Pregnant
Posted on 7/07/2011 5:44:30 AM [#1502 ]
Could ovarian stimulation cause an increase in chromosome copy number abnormalities in the oocytes o
Posted on 6/07/2011 7:11:41 AM [#1494 ]
Study helps disentangle the relationship between maternal, IVF methods and singleton IVF children
Posted on 6/07/2011 7:05:07 AM [#1492 ]
High doses of IVF drugs may cause harm to eggs
Posted on 5/07/2011 8:39:43 AM [#1484 ]
Follicular Phase Endocrine Characteristics during Ovarian Stimulation and GnRH Antagonist Cotreatmen
Posted on 1/07/2011 2:41:16 PM [#1474 ]
Use of in-cycle antimüllerian hormone levels to predict cycle outcome
Posted on 16/06/2011 11:13:42 PM [#1439 ]
ESHRE consensus on the definition of poor response to ovarian stimulation for IVF: the Bologna crite
Posted on 16/06/2011 7:00:32 AM [#1449 ]
Live birth chances in women with extremely low-serum anti-Mullerian hormone levels
Posted on 15/06/2011 8:41:44 PM [#1447 ]
Follicular Phase Endocrine Characteristics during Ovarian Stimulation and GnRH Antagonist Cotreatmen
Posted on 31/05/2011 11:49:29 AM [#1379 ]
IVFLabOnline - Recent Enteries to IVFLabOnlines product listings. see IVFLabonline
Aire-Alert View
Live Monitoring,PPB Volatile Organic Compounds (VOC),Temperature,Relative Humidity. (no web link available).  
LifeAire Systems
Aire-LifeLine View
In-line filter for cylinder and house gasses O2, N2, CO2, and tri-gas. Aire~LifeLine provides in-line air filtration with top of the line protection, delivering a better and more consistent yield of cylinder and house gasses for a wide range of med  
LifeAire Systems
Vit Kit - Warm NX Catalog ID: 90183 View
Vit Kit - Warm NX is an adaptable, cost-effective system for use in the thawing of oocytes, pronuclear zygotes, cleavage stage embryos, and blastocyst stage embryos. Unlike many vitrification kits that feature a mono-buffered system and M199 base med  
Irvine Scientific
Vit Kit - Freeze NX View
Vit Kit - Freeze NX is an adaptable, cost-effective system for use in the vitrification of oocytes, pronuclear zygotes, cleavage stage embryos, and blastocyst stage embryos. Vit Kit - Freeze NX is the latest advancement in vitrification media aimed t  
Irvine Scientific
S-CRYOLOCK - Blue Vitrification device View
S-Cryolock is the slimmer version of the original. It is a versatile, simple and efficient vitrification device that is intended for the holding, cryopreservation and storage of oocytes or embryos in liquid nitrogen.  
Irvine Scientific

This web site is NOT intended to provide medical, diagnosis or treatment
© FertAid Pty Ltd. 2002 - 2023 - all pages. All rights reserved.